Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(tert-Butoxycarbonyl)-4-(p-toluenesulfonyloxy)piperidine → 5-(3,4-dimethoxyphenyl)-4,4-diethyl-2-piperidin-4-yl-2,4-dihydro-3H-pyrazol-3-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(tert-Butoxycarbonyl)-4-(p-toluenesulfonyloxy)piperidine | HCID 15734713 | — |
| 반응물 | 5-(3,4-dimethoxyphenyl)-4,4-diethyl-2,4-dihydro-3H-pyrazol-3-one | HCID 66616622 | — |
| 생성물 | 5-(3,4-dimethoxyphenyl)-4,4-diethyl-2-piperidin-4-yl-2,4-dihydro-3H-pyrazol-3-one | HCID 66616474 | — |
반응 단계
Prepared analogously as described for the example B1 (Alternative 1) using 5-(3,4-dimethoxyphenyl)-4,4-diethyl-2,4-dihydro-3H-pyrazol-3-one (compound C7) and tert-butyl 4-(Toluene-4-sulfonyloxy)piperidine-1-carboxylate (compound E1) as starting compounds resulting in the title compound. (compound B7)
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08609848B2 |
| 출처 데이터셋 | uspto-grants-2013_12 |
| ORD ID | ord-a7bfe601f7184030a696ae6109da24a0 |
| 출처 메모 | uspto-grants-2013_12 |